Screening of biomarkers for liver adenoma in low-dose-rate γ-ray-irradiated mice

References

• Ahronian LG, Zhu LJ, Chen YW, Chu HC, Klimstra DS, Lewis BC. 2016. A novel KLF6-Rho GTPase axis regulates hepatocellular carcinoma cell migration and dissemination. Oncogene. 35:4653–4662.
   PubMed Web of Science ®Google Scholar
• Anderson SP, Dunn C, Laughter A, Yoon L, Swanson C, Stulnig TM, Steffensen KR, Chandraratna RA, Gustafsson JA, Corton JC. 2004. Overlapping transcriptional programs regulated by the nuclear receptors peroxisome proliferator-activated receptor alpha, retinoid X receptor, and liver X receptor in mouse liver. Mol Pharmacol. 66:1440–1452.
   PubMed Web of Science ®Google Scholar
• Bouly M, Masson D, Gross B, Jiang XC, Fievet C, Castro G, Tall AR, Fruchart JC, Staels B, Lagrost L, et al. 2001. Induction of the phospholipid transfer protein gene accounts for the high density lipoprotein enlargement in mice treated with fenofibrate. J Biol Chem. 276:25841–25847.
   PubMed Web of Science ®Google Scholar
• Chu R, Lim H, Brumfield L, Liu H, Herring C, Ulintz P, Reddy JK, Davison M. 2004. Protein profiling of mouse livers with peroxisome proliferator-activated receptor alpha activation. Mol Cell Biol. 24:6288–6297.
   PubMed Web of Science ®Google Scholar
• Conner EA, Lemmer ER, Omori M, Wirth PJ, Factor VM, Thorgeirsson SS. 2000. Dual functions of E2F-1 in a transgenic mouse model of liver carcinogenesis. Oncogene. 19:5054–5062.
   PubMed Web of Science ®Google Scholar
• Corton JC, Fan LQ, Brown S, Anderson SP, Bocos C, Cattley RC, Mode A, Gustafsson JA. 1998. Down-regulation of cytochrome P450 2C family members and positive acute-phase response gene expression by peroxisome proliferator chemicals. Mol Pharmacol. 54:463–473.
   PubMed Web of Science ®Google Scholar
• David G, Terris B, Marchio A, Lavau C, Dejean A. 1997. The acute promyelocytic leukemia PML-RAR alpha protein induces hepatic preneoplastic and neoplastic lesions in transgenic mice. Oncogene. 14:1547–1554.
   PubMed Web of Science ®Google Scholar
• Du YC, Chou CK, Klimstra DS, Varmus H. 2011. Receptor for hyaluronan-mediated motility isoform B promotes liver metastasis in a mouse model of multistep tumorigenesis and a tail vein assay for metastasis. Proc Natl Acad Sci USA. 108:16753–16758.
   PubMed Web of Science ®Google Scholar
• Eferl R, Ricci R, Kenner L, Zenz R, David JP, Rath M, Wagner EF. 2003. Liver tumor development: c-Jun antagonizes the proapoptotic activity of p53. Cell. 112:181–192.
   PubMed Web of Science ®Google Scholar
• Gardmo C, Mode A. 2006. In vivo transfection of rat liver discloses binding sites conveying GH-dependent and female-specific gene expression. J Mol Endocrinol. 37:433–441.
   PubMed Web of Science ®Google Scholar
• Gopinathan L, Tan SL, Padmakumar VC, Coppola V, Tessarollo L, Kaldis P. 2014. Loss of Cdk2 and cyclin A2 impairs cell proliferation and tumorigenesis. Cancer Res. 74:3870–3879.
   PubMed Web of Science ®Google Scholar
• Goto T, Lee JY, Teraminami A, Kim YI, Hirai S, Uemura T, Inoue H, Takahashi N, Kawada T. 2011. Activation of peroxisome proliferator-activated receptor-alpha stimulates both differentiation and fatty acid oxidation in adipocytes. J Lipid Res. 52:873–884.
   PubMed Web of Science ®Google Scholar
• Gloerich J, van Vlies N, Jansen GA, Denis S, Ruiter JP, van Werkhoven MA, Duran M, Vaz FM, Wanders RJ, Ferdinandusse S. 2005. A phytol-enriched diet induces changes in fatty acid metabolism in mice both via PPARalpha-dependent and -independent pathways. J Lipid Res. 46:716–726.
   PubMed Web of Science ®Google Scholar
• Gupta SK, Oommen S, Aubry MC, Williams BP, Vlahakis NE. 2013. Integrin α9β1 promotes malignant tumor growth and metastasis by potentiating epithelial-mesenchymal transition. Oncogene. 32:141–150.
   PubMed Web of Science ®Google Scholar
• Hashimoto T, Cook WS, Qi C, Yeldandi AV, Reddy JK, Rao MS. 2000. Defect in peroxisome proliferator-activated receptor alpha-inducible fatty acid oxidation determines the severity of hepatic steatosis in response to fasting. J Biol Chem. 275:28918–28928.
   PubMed Web of Science ®Google Scholar
• Hays T, Rusyn I, Burns AM, Kennett MJ, Ward JM, Gonzalez FJ, Peters JM. 2005. Role of peroxisome proliferator-activated receptor-alpha (PPARalpha) in bezafibrate-induced hepatocarcinogenesis and cholestasis. Carcinogenesis. 26:219–227.
   PubMed Web of Science ®Google Scholar
• Hefetz-Sela S, Stein I, Klieger Y, Porat R, Sade-Feldman M, Zreik F, Nagler A, Pappo O, Quagliata L, Dazert E, et al. 2014. Acquisition of an immunosuppressive protumorigenic macrophage phenotype depending on c-Jun phosphorylation. Proc Natl Acad Sci USA. 111:17582–17587.
   PubMed Web of Science ®Google Scholar
• Hoenerhoff MJ, Pandiri AR, Lahousse SA, Hong HH, Ton TV, Masinde T, Auerbach SS, Gerrish K, Bushel PR, Shockley KR, et al. 2011. Global gene profiling of spontaneous hepatocellular carcinoma in B6C3F1 mice: similarities in the molecular landscape with human liver cancer. Toxicol Pathol. 39:678–699.
   PubMed Web of Science ®Google Scholar
• Huang J, Jia Y, Fu T, Viswakarma N, Bai L, Rao MS, Zhu Y, Borensztajn J, Reddy JK. 2012. Sustained activation of PPARα by endogenous ligands increases hepatic fatty acid oxidation and prevents obesity in ob/ob mice. FASEB J. 26:628–638.
   PubMed Web of Science ®Google Scholar
• Hunt MC, Yang YZ, Eggertsen G, Carneheim CM, Gåfvels M, Einarsson C, Alexson SE. 2000. The peroxisome proliferator-activated receptor alpha (PPARalpha) regulates bile acid biosynthesis. J Biol Chem. 275:28947–28953.
   PubMed Web of Science ®Google Scholar
• Jeganathan K, Malureanu L, Baker DJ, Abraham SC, van Deursen JM. 2007. Bub1 mediates cell death in response to chromosome missegregation and acts to suppress spontaneous tumorigenesis. J Cell Biol. 179:255–267.
   PubMed Web of Science ®Google Scholar
• Kersten S, Mandard S, Escher P, Gonzalez FJ, Tafuri S, Desvergne B, Wahli W. 2001. The peroxisome proliferator-activated receptor alpha regulates amino acid metabolism. FASEB J. 15:1971–1978.
   PubMed Web of Science ®Google Scholar
• Lawler J, Miao WM, Duquette M, Bouck N, Bronson RT, Hynes RO. 2001. Thrombospondin-1 gene expression affects survival and tumor spectrum of p53-deficient mice. Am J Pathol. 159:1949–1956.
   PubMed Web of Science ®Google Scholar
• Man K, Ng KT, Xu A, Cheng Q, Lo CM, Xiao JW, Sun BS, Lim ZX, Cheung JS, Wu EX, et al. 2010. Suppression of liver tumor growth and metastasis by adiponectin in nude mice through inhibition of tumor angiogenesis and downregulation of Rho kinase/IFN-inducible protein 10/matrix metalloproteinase 9 signaling. Clin Cancer Res. 16:967–977.
   PubMed Web of Science ®Google Scholar
• Maronpot RR. 1999. Pathology of the mouse. Vienna: Cache River Press. p. 146–147.
   Google Scholar
• Marshall A, Lukk M, Kutter C, Davies S, Alexander G, Odom DT. 2013. Global gene expression profiling reveals SPINK1 as a potential hepatocellular carcinoma marker. PLoS One. 8:e59459.
   PubMed Web of Science ®Google Scholar
• Nakamoto Y, Kaneko S, Fan H, Momoi T, Tsutsui H, Nakanishi K, Kobayashi K, Suda T. 2002. Prevention of hepatocellular carcinoma development associated with chronic hepatitis by anti-fas ligand antibody therapy. J Exp Med. 196:1105–1111.
   PubMed Web of Science ®Google Scholar
• Nakamura S, Tanaka IB 3rd, Tanaka S, Nakaya K, Sakata N, Oghiso Y. 2010. Adiposity in female B6C3F1 mice continuously irradiated with low-dose-rate gamma rays. Radiat Res. 173:333–341.
   PubMed Web of Science ®Google Scholar
• Nejak-Bowen KN, Monga SP. 2011. Beta-catenin signaling, liver regeneration and hepatocellular cancer: sorting the good from the bad. Semin Cancer Biol. 2011:44–58.
   Google Scholar
• Nielsen R, Grøntved L, Stunnenberg HG, Mandrup S. 2006. Peroxisome proliferator-activated receptor subtype- and cell-type-specific activation of genomic target genes upon adenoviral transgene delivery. Mol Cell Biol. 26:5698–5714.
   PubMed Web of Science ®Google Scholar
• Park I, Lee HO, Choi E, Lee YK, Kwon MS, Min J, Park PG, Lee S, Kong YY, Gong G, et al. 2013. Loss of BubR1 acetylation causes defects in spindle assembly checkpoint signaling and promotes tumor formation. J Cell Biol. 202:295–309.
   PubMed Web of Science ®Google Scholar
• Peters JM, Aoyama T, Cattley RC, Nobumitsu U, Hashimoto T, Gonzalez FJ. 1998. Role of peroxisome proliferator-activated receptor alpha in altered cell cycle regulation in mouse liver. Carcinogenesis. 19:1989–1994.
   PubMed Web of Science ®Google Scholar
• Satow R, Shitashige M, Kanai Y, Takeshita F, Ojima H, Jigami T, Honda K, Kosuge T, Ochiya T, Hirohashi S, et al. 2010. Combined functional genome survey of therapeutic targets for hepatocellular carcinoma. Clin Cancer Res. 16:2518–2528.
   PubMed Web of Science ®Google Scholar
• Schliekelman M, Cowley DO, O'Quinn R, Oliver TG, Lu L, Salmon ED, Van Dyke T. 2009. Impaired Bub1 function in vivo compromises tension-dependent checkpoint function leading to aneuploidy and tumorigenesis. Cancer Res. 69:45–54.
   PubMed Web of Science ®Google Scholar
• Sher T, Yi HF, McBride OW, Gonzalez FJ. 1993. cDNA cloning, chromosomal mapping, and functional characterization of the human peroxisome proliferator activated receptor. Biochemistry. 32:5598–5604.
   PubMed Web of Science ®Google Scholar
• Shiragai A, Saitou M, Kudo I, kanawaiwa-kudo S, Matsumoto T, Furuse T, Yanai T, Ichinohe K, Sato F, Ohmomo Y. 1997. Estimation of the absorbed dose to mice in prolonged irradiation by low-dose rate γ-rays from 137Cs sources. Radioistope. 46:904–911.
   Google Scholar
• Sugihara T, Magae J, Wadhwa R, Kaul SC, Kawakami Y, Matsumoto T, Tanaka K. 2004. Dose and dose-rate effects of low-dose ionizing radiation on activation of Trp53 in immortalized murine cells. Radiat Res. 162:296–307.
   PubMed Web of Science ®Google Scholar
• Sun H, Yu L, Wei H, Liu G. 2012. A novel antihepatitis drug, bicyclol, prevents liver carcinogenesis in diethylnitrosamine-initiated and phenobarbital-promoted mice tumor model. J Biomed Biotechnol. 2012:584728.
   PubMedGoogle Scholar
• Tanaka IB, 3rd IB, Komura J, Tanaka S. 2017. Pathology of serially sacrificed female B6C3F1 mice continuously exposed to very low dose-rates of gamma rays. Radiat Res. 187:346–360.
   PubMed Web of Science ®Google Scholar
• Tanaka IB, 3rd IB, Tanaka S, Ichinohe K, Matsushita S, Matsumoto T, Otsu H, Oghiso Y, Sato F. 2007. Cause of death and neoplasia in mice continuously exposed to very low dose rates of gamma rays. Radiat Res. 167:417–437.
   PubMed Web of Science ®Google Scholar
• Tanaka S, Tanaka IB, 3rd, Sasagawa S, Ichinohe K, Takabatake T, Matsushita S, Matsumoto T, Otsu H, Sato F. 2003. No lengthening of life span in mice continuously exposed to gamma rays at very low dose rates. Radiat Res. 160:376–379.
   PubMed Web of Science ®Google Scholar
• Tanaka H, Yamamoto M, Hashimoto N, Miyakoshi M, Tamakawa S, Yoshie M, Tokusashi Y, Yokoyama K, Yaginuma Y, Ogawa K. 2006. Hypoxia-independent overexpression of hypoxia-inducible factor 1alpha as an early change in mouse hepatocarcinogenesis. Cancer Res. 66:11263–11270.
   PubMed Web of Science ®Google Scholar
• Uehara Y, Ito Y, Taki K, Nenoi M, Ichinohe K, Nakamura S, Tanaka S, Oghiso Y, Tanaka K, Matsumoto T, et al. 2010. Gene expression profile in mouse liver after long term low dose-rate irradiation with gamma-rays. Radiat Res. 174:611–617.
   PubMed Web of Science ®Google Scholar
• Valasek MA, Clarke SL, Repa JJ. 2007. Fenofibrate reduces intestinal cholesterol absorption via PPARalpha-dependent modulation of NPC1L1 expression in mouse. J Lipid Res. 48:2725–2735.
   PubMed Web of Science ®Google Scholar
• Wan YJ, Cai Y, Lungo W, Fu P, Locker J, French S, Sucov HM. 2000. Peroxisome proliferator-activated receptor alpha-mediated pathways are altered in hepatocyte-specific retinoid X receptor alpha-deficient mice. J Biol Chem. 275:28285–28290.
   PubMed Web of Science ®Google Scholar
• Weber J, Öllinger R, Friedrich M, Ehmer U, Barenboim M, Steiger K, Heid I, Mueller S, Maresch R, Engleitner T, et al. 2015. CRISPR/Cas9 somatic multiplex-mutagenesis for high-throughput functional cancer genomics in mice. Proc Natl Acad Sci USA. 112:13982–13987.
   PubMed Web of Science ®Google Scholar
• Yan F, Wang Q, Xu C, Cao M, Zhou X, Wang T, Yu C, Jing F, Chen W, Gao L, et al. 2014. Peroxisome proliferator-activated receptor α activation induces hepatic steatosis, suggesting an adverse effect. PLoS One. 9:e99245.
   PubMed Web of Science ®Google Scholar
• Yang X, Lin Y, Shi Y, Li B, Liu W, Yin W, Dang Y, Chu Y, Fan J, He R. 2016. FAP promotes immunosuppression by cancer-associated fibroblasts in the tumor microenvironment via STAT3-CCL2 signaling. Cancer Res. 76:4124–4135.
   PubMed Web of Science ®Google Scholar
• Zhou L, Liu J, Luo F. 2006. Serum tumor markers for detection of hepatocellular carcinoma. World J Gastroenterol. 12:1175–1181.
   PubMed Web of Science ®Google Scholar